Shoulder

Early stage orthopedic device company, Soft Tissue Regeneration, has developed a breakthrough tissue engineering platform used to regenerate ligaments and tendons. The company has announced that it has received FDA clearance to market its STR GRAFT, a biodegradable scaffold used for soft tissue augmentation and rotator cuff repair.

Orthopaedic and Sports Med company DePuy Mitek, Inc., has announced the launch of the Healix Advance™ Family of Suture Anchors, a comprehensive new system of rotator cuff anchor and instrumentation solutions. The company says its new anchor design will enable faster insertion into hard bone and maximise fixation and pull-out strength.

Breg, Inc., has announced the appointment of Stuart M. Essig as chairman of the board. Mr. Essig retired from the position of Chief Executive Officer at Integra LifeSciences Holdings Corporation earlier this year.

Cayenne medical has chosen the annual AOSSM meeting at which to launch its full line of anchors which it says are designed to answer market demand for improved procedural technique and cost- efficiency

Zimmer Holdings Inc chose last week’s EFORT congress at which to launch its Sidus™ Stem-Free Shoulder system which it claims is ideal for patients with early to mid-stage osteoarthritis.

The big surprise in this new study, published at AANA this week, is that it’s taken so long for researchers to put a figure on the cost savings to be had in saline consumption alone by using an inflow/outflow computer controlled arthroscopic pump rather than inflow only. Maybe its just a sign of the times that it’s even become an issue.

You’d have thought ligament fixation device design had been done to death, but marginal benefits still count in what is a sizeable market, so Smith & Nephew’s new “open architecture” anchor should find customers. After twenty years of anchors, quite what a shoulder surgeon might be so dissatisfied with that this new device addresses is beyond us, but it looks a smart enough idea.

Integra sees fruits of its acquisition of Ascension Orthopaedics in the form of first European implants of the company’s shoulder resurfacing arthroplasty.

It’s a bit of a journalistic open goal when BBC publishes on the fate of “cremated” prostheses at the same time as we’re wondering about the fate of the Costa Concordia. Sounds like they might both end up as wind turbines.

Suspension Orthopaedics has gained FDA clearance for some interesting clavicle plates addressing specific problems associated with clavicular fracture.

DePuy Orthopaedics unveils advancements in orthopaedic treatment at AAOS. Focus is on Clinical and Economic Value, Procedural Efficiency, Personalization.

They’re all at it! Tornier now tells us what it’s up to at AAOS.

Arthrex relies on surgeon training in “wet labs” as a major tool in its marketing mix. Now the company has overcome objection from locals in Vail and gained permission to finish building such a facility.

AAOS is on right now in San Francisco. Here are Stryker’s “showcased” offerings from the event.

Exactech’s marketing communications doing a good job of attracting you to their AAOS booth by explaining what you’ll find when you get there.

Biomet, Inc., has announced FDA clearance of two new products; the E1® humeral bearing for use with the Comprehensive® Reverse Shoulder System, and the Comprehensive® Segmental Revision System.